• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: Benzophenone-3, octylmethoxycinnamate, avobenzone, titanium dioxide, zinc oxide
Date Designated: 08/13/2001
Orphan Designation: For the prevention of visible light induced skin photosensitivity as a result of porfimer sodium photodynamic therapy
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Fallien Cosmeceuticals Ltd.
677 W. Dekalb Pike
King of Prussia, Pennsylvania 19406
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.